Citations

Showing 10 of 107964 citations.

Improvement in Outcomes of Clinical Islet Transplantation: 1999–2010
Barton, Franca B. , Rickels, Michael R. , Alejandro, Rodolfo , Hering, Bernhard J. , Wease, Stephen, Oberholzer, José , Garfinkel, Marc R., Levy, Marlon F. , Pattou, François , Berney, Thierry , Secchi, Antonio , Messinger, Shari , Senior, Peter , Maffi, Paola , Posselt, Andrew M., Stock, Peter G. , Luo, Xunrong , Kandeel, Fouad , Cagliero, Enrico, Turgeon, Nicole A. , Naji, Ali , Greenbaum, Carla J. , Kudva, Yogish C. , Brayman, Kenneth L. , Aull, Meredith J. , Kay, Tom, Fernandez, Luis A. , Vantyghem, Marie‐Christine , Naziruddin, Bashoo , Odorico, Jon S. , Kaufman, Dixon B. , Witkowski, Piotr , O’Connell, Philip J. , Larsen, Christian P. , Bellin, Melena D. , Shapiro, A. M. James , Berney, Thierry , Rickels, Michael R , Messinger, Shari , Pattou, F

Mayo Clinic

Diabetes Care | June 22, 2012 | Volume: 35 | Issue: 7 | Pages: 1436-1445

10.2337/dc12-0063 | PMID 22723582 Get It

OBJECTIVE To describe trends of primary efficacy and safety outcomes of islet transplantation in type 1 diabetes recipients with severe hypoglycemia from the Collaborative Islet Transplant Registry (CITR) from 1999 to 2010. RESEARCH DESIGN AND METHODS A total of 677 islet transplant-alone or islet-after-kidney recipients with type 1 diabetes in the CITR were analyzed for five primary efficacy outcomes and overall safety to identify any differences by early (1999–2002), mid (2003–2006), or recent (2007–2010) transplant era based on annual follow-up to 5 years. RESULTS Insulin independence at 3 years after transplant improved from 27% in the early era (1999–2002, n = 214) to 37% in the mid (2003–2006, n = 255) and to 44% in the most recent era (2007–2010, n = 208; P = 0.006 for years-by-era; P = 0.01 for era alone). C-peptide ≥0.3 ng/mL, indicative of islet graft function, was retained longer in the most recent era (P < 0.001). Reduction of HbA1c and resolution of severe hypoglycemia exhibited enduring long-term effects. Fasting blood glucose stabilization also showed improvements in the most recent era. There were also modest reductions in the occurrence of adverse events. The islet reinfusion rate was lower: 48% by 1 year in 2007–2010 vs. 60–65% in 1999–2006 (P < 0.01). Recipients that ever achieved insulin-independence experienced longer duration of islet graft function (P < 0.001). CONCLUSIONS The CITR shows improvement in primary efficacy and safety outcomes of islet transplantation in recipients who received transplants in 2007–2010 compared with those in 1999–2006, with fewer islet infusions and adverse events per recipient.
Is HOT a Cool Treatment for Type 1 Diabetes?
Rajagopalan, Govindarajan , Kudva, Yogish C. , David, Chella S.

Mayo Clinic

Diabetes | June 22, 2012 | Volume: 61 | Issue: 7 | Pages: 1664-1666

10.2337/db12-0527 | PMID 22723274 Get It

Neural Networks, Cognition, and Diabetes: What Is the Connection?
Jones, David T.

Mayo Clinic

Diabetes | June 22, 2012 | Volume: 61 | Issue: 7 | Pages: 1653-1655

10.2337/db12-0402 | PMID 22723270 Get It

Trafficking defects inWASH-knockout fibroblasts originate from collapsed endosomal and lysosomal networks
Gomez, Timothy S., Gorman, Jacquelyn A. , Narvajas, Amaia Artal-Martinez de, Köenig, Alexander , Billadeau, Daniel D. , Narvajas, A A-M de

Mayo Clinic

Molecular Biology of the Cell | June 21, 2012 | Volume: 23 | Issue: 16 | Pages: 3215-3228

10.1091/mbc.e12-02-0101 | PMID 22718907 Get It

The Arp2/3-activator Wiskott–Aldrich syndrome protein and Scar homologue (WASH) is suggested to regulate actin-dependent membrane scission during endosomal sorting, but its cellular roles have not been fully elucidated. To investigate WASH function, we generated tamoxifen-inducible WASH-knockout mouse embryonic fibroblasts (WASHout MEFs). Of interest, although EEA1+endosomes were enlarged, collapsed, and devoid of filamentous-actin and Arp2/3 in WASHout MEFs, we did not observe elongated membrane tubules emanating from these disorganized endomembranes. However, collapsed WASHout endosomes harbored segregated subdomains, containing either retromer cargo recognition complex–associated proteins or EEA1. In addition, we observed global collapse of LAMP1+lysosomes, with some lysosomal membrane domains associated with endosomes. Both epidermal growth factor receptor (EGFR) and transferrin receptor (TfnR) exhibited changes in steady-state cellular localization. EGFR was directed to the lysosomal compartment and exhibited reduced basal levels in WASHout MEFs. However, although TfnR was accumulated with collapsed endosomes, it recycled normally. Moreover, EGF stimulation led to efficient EGFR degradation within enlarged lysosomal structures. These results are consistent with the idea that discrete receptors differentially traffic via WASH-dependent and WASH-independent mechanisms and demonstrate that WASH-mediated F-actin is requisite for the integrity of both endosomal and lysosomal networks in mammalian cells.
External Quality Assessment of Platelet Disorder Investigations: Results of International Surveys on Diagnostic Tests for Dense Granule Deficiency and Platelet Aggregometry Interpretation
Hayward, Catherine P.M. , Moffat, Karen A. , Plumhoff, Elizabeth, Timleck, Marnie, Hoffman, Suzanne M., Spitzer, Ernie, Cott, Elizabeth Van, Meijer, Piet , Cott, Elizabeth M. Van

Mayo Clinic

Seminars in Thrombosis and Hemostasis | June 21, 2012 | Volume: 38 | Issue: 06 | Pages: 622-631

10.1055/s-0032-1319767 | PMID 22718255 Get It

Targeted therapy of acute myeloid leukemia in 2012: towards individualized therapy
Foran, James M.

Mayo Clinic

Hematology | June 21, 2012 | Volume: 17 | Issue: sup1 | Pages: s137-s140

10.1179/102453312x13336169156456 | PMID 22507802 Get It

JAK2 inhibitors and their impact in myeloproliferative neoplasms
Geyer, Holly L. , Tibes, Raoul , Mesa, Ruben A.

Mayo Clinic

Hematology | June 21, 2012 | Volume: 17 | Issue: sup1 | Pages: s129-s132

10.1179/102453312x13336169156375 | PMID 22507800 Get It

Targeted therapy of multiple myeloma
Kyle, Robert A.

Mayo Clinic

Hematology | June 21, 2012 | Volume: 17 | Issue: sup1 | Pages: s125-s128

10.1179/102453312x13336169156339 | PMID 22507799 Get It

Waldenström macroglobulinemia
Gertz, Morie A.

Mayo Clinic

Hematology | June 21, 2012 | Volume: 17 | Issue: sup1 | Pages: s112-s116

10.1179/102453312x13336169156212 | PMID 22507796 Get It

Novel therapeutics in multiple myeloma
Stewart, A. Keith

Mayo Clinic

Hematology | June 21, 2012 | Volume: 17 | Issue: sup1 | Pages: s105-s108

10.1179/102453312x13336169156131 | PMID 22507794 Get It